S119: PRELIMINARY RESULTS OF A PHASE 1 STUDY IN HEALTHY SUBJECTS ADMINISTERED INCLACUMAB, A FULLY HUMAN IGG4 ANTI-P-SELECTIN MONOCLONAL ANTIBODY IN DEVELOPMENT FOR TREATMENT OF SICKLE CELL DISEASE

Bibliographic Details
Main Authors: C Mayer, D Cooper, A Redfern, X Geng, J Shi, M Zutphen-van Geffen, I Kuan, K Koek, H Kastrissios, K Patel, M Davis, P Yue
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000821444.06029.7c